New Drugs For MS on the Horizon

Multiple sclerosis is a condition that impacts the human body's autoimmune system and as such has to date been thought to be incurable. The only issue that the medical world has been capable to perform is to manage the many symptoms by the use of various drugs. A single of problems faced is that although the ailment has equivalent effects on the brain and also the myelin sheath around the spinal cord the symptoms differ substantially from one patient to another. This makes it essential to use a number of drugs for MS therapies.

You'll find at present two new drugs for MS becoming evaluated for their effectiveness and many doctors have high hopes for their good results. In the final handful of years there have not been a lot of new effective drugs coming on towards the market place the final a single Tysabri won speedy FDA approval and was then plagued by reports of many patients contracting progressive multifocal leukoencephalopathy, that is a fatal viral illness. While still obtainable underneath a unique program its effectiveness is offset by these problems. This has led to the development of those 2 new drugs.

One of the drugs for MS is Fingolimod; although not necessarily a "new" drug it is getting effectively evaluated for use in sufferers with multiple sclerosis. Initially developed for use in organ transfer individuals the drug is created to block a signal that makes it possible for T-cell lymphocytes to enter the brain. Inside a check involving 173 sufferers who had been diagnosed with relapsing-remitting MS, they were found to endure a 30% decrease in relapses more than a 3 year period as opposed to those check subjects who took a placebo. 1 of the other advantages to Fingolimod is the fact that it's a pill that can be taken orally instead of an injection.

The other one of the new drugs for MS getting evaluated is Alemtuzumab; this medication was approved by the FDA to help inside the fight against leukemia. In a report not too long ago published in the New England Journal of Medicine a test was performed with 334 individuals who had been diagnosed within the early stages of relapsing-remitting multiple sclerosis. The check involved comparing the outcomes of each the Alemtuzumab and an already approved medication interferon beta-1a. The results showed a relapse rate of 2/3 less in the individuals taking the Alemtuzumab as compared to these on interferon. These new medications may be what the multiple sclerosis world has been waiting for, only time will inform.


- The Multiple Sclerosis-Reversing Breakthrough - Download Now
A scientific breakthrough technology for curing Multiple Sclerosis...

- My Story: One Woman's Journey With Multiple Sclerosis - Download Now
One MS sufferer shares her touching life story and remarkable "miracle cure" diet in this new ebook...